Key result
Higher serum A-FABP is independently linked to increased aortic stiffness in nondialysis CKD.
Cross-Sectional (n=270)
Answers are grounded in this paper and cite their sources.
Cross-sectional study demonstrates serum A-FABP independently associates with aortic stiffness in nondialysis chronic kidney disease, indicating a potential marker of vascular damage.
Aortic stiffness (AS) is a major predictor of cardiovascular disease and mortality in patients with chronic kidney disease (CKD) and adipocyte fatty acid-binding protein (A-FABP) is a novel adipokine that is positively correlated with AS in the general population. Therefore, we investigated the correlation between serum A-FABP levels and AS in nondialysis CKD patients. Fasting blood samples and baseline characteristics were obtained in 270 patients with nondialysis CKD. Serum A-FABP concentrations were determined by enzyme immunoassay and carotid-femoral pulse wave velocity (cfPWV) measurements were acquired using a validated tonometry system. Patients with cfPWV >10 m/s formed the AS group, while those with values ≤10 m/s comprised the comparison group. Among 270 CKD patients, 92 patients (34.1%) were in the AS group. Compared to those in the comparison group, patients in the AS group were older (P < .001), had a higher prevalence of diabetes, along with higher serum A-FABP level (P < .001), larger waist circumference (P = .004), and lower estimated glomerular filtration rate (P = .001) but higher levels of body fat mass (P = .010), systolic blood pressure (P < .001), fasting glucose (P = .014), blood urea nitrogen (P = .009), and serum creatinine (P = .004). The serum log-A-FABP level was positively associated with log-cfPWV (β = 0.178, P = .001) in nondialysis CKD patients and multivariable logistic regression analysis identified serum A-FABP (P = .006), age (P = .001), and systolic blood pressure (P = .015) as independent predictors of AS in nondialysis-dependent CKD patients. Elevated A-FABP levels may be a significant predictor of AS in nondialysis CKD patients.
No takes yet. Share an insight, caveat, or question.
Su et al. (2022) conducted a cross-sectional in Nondialysis chronic kidney disease (n=270). Serum adipocyte fatty acid-binding protein (A-FABP) level vs. Patients without aortic stiffness (cfPWV ≤10 m/s) was evaluated on Aortic stiffness (defined as carotid-femoral pulse wave velocity [cfPWV] >10 m/s) (β 0.178, p=.001). Serum A-FABP independently predicted aortic stiffness and log-A-FABP positively correlated with log-cfPWV in nondialysis CKD patients.
Synapse has enriched 10 related papers. Consider them for comparative context: